~~<i id='4477F42424'><strike id='4477F42424'><tt id='4477F42424'><pre id='4477F42424'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：hotspot 2025-08-03 10:47:58 - browse：2

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Scientists grapple with ethics of stem cell research

Wikipedia

entertainment

Wikipedia

explore

knowledge

hotspot

DarronCummings/APEliLillysaidTuesdaythatitwillpurchaseDICETherapeutics,asmallcompanydevelopinganexpe

WSS

5 takeaways from STAT's examination of Zynex Medical

Dementia risk linked to living in disadvantaged areas: Study

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Pharma companies must ensure equitable access to obesity drugs

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Wikipedia

leisure time

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Medicare details structure of new drug price negotiation program

Pharma companies must ensure equitable access to obesity drugs

Trump demands the U.S. pay no more for drugs than other countries … again

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Anesthesiologist group: stop taking Ozempic before surgery

'CMA Fest' 2023: How to watch, who is performing and more

entertainment

Stephen Quake on the Chan Zuckerberg quest to conquer disease

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Judge denies Trump's request for new trial in E. Jean Carroll case

My daughter's legacy lives on through her writing, phage therapy

NIH tests clinical research in primary care with $30 million program

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Wikipedia

explore

knowledge

hotspot